G

Ganga Pharmaceuticals Ltd 539680.BO

₹12.00

Last Updated: Feb 12, 12:00 AM·BSE

539680.BO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 06, 2024

Report Source: 2024 2nd Quarter Report

G

Ganga Pharmaceuticals Ltd. Stock Analysis 539680.BO

India Consumer Staples Nano Cap Report:
Ganga Pharmaceuticals Ltd. engages in the manufacturing and trading of pharmaceuticals and allied products. The company is headquartered in Mumbai, Maharashtra and currently employs 17 full-time employees. The company went IPO on 2016-02-22. The firm is engaged in the production of ayurvedic medicine. Apart from manufacturing, the Company is also into marketing and distribution of ayurvedic medicines. The company offers ayurvedic medicines for acidity, antidandruff, antioxidants, blood purifier and skin disorder, constipation, cough and cold, dental care, diarrhea, ear care, female tonic, hair care, hemorrhoids and piles, indigestion, iron tonic, joint pains, kidney stone, liver disorder, rejuvenation tonic, sleep inducers, and offers herbal cosmetics. Its products include Asuka tablets, Dendroil, Ashwo tablets-tonic for body and mind; Raktaj tablets/syrup for skin disorders; Nirmalaya that relieves constipation; Khadira tablets (80 mg.) that relieves cough; Danta Doshahar Manjan for gum and teeth protective; Holetrica capsule that checks diarrhea and corrects digestion; Karnaraj drops ear drops, Femoherb syrup/tablets, and Mahabhrungraj oil.
Read More

Ganga Pharmaceuticals Ltd (539680.BO) Chart

Key Statistics of Ganga Pharmaceuticals Ltd (539680.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹12.00₹12.00

Today's Open

₹12.00

Volume

8000.00

P/E Ratio (TTM)

90.07

52 Week Range

₹9.35₹14.80

Market Cap

71.05M

Avg. Volume

18.67K

Dividend Yield

-

Financial Metrics & Statements of Ganga Pharmaceuticals Ltd (539680.BO)

FAQ's for Ganga Pharmaceuticals Ltd (539680.BO)

  • According to Musaffa’s Shariah screening methodology, Ganga Pharmaceuticals Ltd (539680.BO) is currently classified as NOT HALAL as of February 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.